APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hereditary Disease Testing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hereditary Disease Testing Industry Growth and Trends Forecast to 2032

1 January 2026113 pages

Choose your research edition.

Industry ResearchHereditary Disease Testing Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hereditary Disease Testing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Hereditary Disease Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hereditary Disease Testing Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hereditary Disease Testing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

According to APO Research, the global Hereditary Disease Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hereditary Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hereditary Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hereditary Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Hereditary Disease Testing market include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical and Agilent Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hereditary Disease Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hereditary Disease Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hereditary Disease Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hereditary Disease Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Hereditary Disease Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hereditary Disease Testing Market by Company

Myriad Genetics

Invitae

Illumina

Natera

Laboratory Corporation of America Holdings

F. Hoffmann-La Roche

Quest Diagnostics

CooperSurgical

Agilent Technologies

Thermo Fisher Scientific

Twist Bioscience

Sophia Genetics

Fulgent Genetic

Medgenome

CENTOGENE

Hereditary Disease Testing Segment by Type

Hereditary Cancer Testing

Hereditary Non-cancer Testing

Hereditary Disease Testing Segment by Application

Hospital

Clinic

Laboratory

Others

Hereditary Disease Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hereditary Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hereditary Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hereditary Disease Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Hereditary Disease Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Hereditary Disease Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Hereditary Disease Testing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Hereditary Disease Testing Market Share by Region (2021-2026) Table 4. Global Hereditary Disease Testing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Hereditary Disease Testing Market Share by Region (2027-2032) Table 6. Global Hereditary Disease Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hereditary Disease Testing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Hereditary Disease Testing Market Size Share by Type (2021-2026) Table 9. Global Hereditary Disease Testing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Hereditary Disease Testing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Hereditary Disease Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Hereditary Disease Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Hereditary Disease Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Hereditary Disease Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Hereditary Disease Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Hereditary Disease Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Hereditary Disease Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Hereditary Disease Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Hereditary Disease Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Hereditary Disease Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Hereditary Disease Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Hereditary Disease Testing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Hereditary Disease Testing Market Size Share by Application (2021-2026) Table 24. Global Hereditary Disease Testing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Hereditary Disease Testing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Hereditary Disease Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Hereditary Disease Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Hereditary Disease Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Hereditary Disease Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Hereditary Disease Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Hereditary Disease Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Hereditary Disease Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Hereditary Disease Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Hereditary Disease Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Hereditary Disease Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Hereditary Disease Testing Industry Trends Table 37. Hereditary Disease Testing Industry Drivers Table 38. Hereditary Disease Testing Industry Opportunities and Challenges Table 39. Hereditary Disease Testing Industry Restraints Table 40. Global Hereditary Disease Testing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Hereditary Disease Testing Revenue Market Share by Company (2021-2026) Table 42. Global Hereditary Disease Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Hereditary Disease Testing Key Company Headquarters & Area Served Table 44. Global Hereditary Disease Testing Company, Product Type & Application Table 45. Global Hereditary Disease Testing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Hereditary Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Myriad Genetics Company Information Table 49. Myriad Genetics Business Overview Table 50. Myriad Genetics Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Myriad Genetics Hereditary Disease Testing Product Portfolio Table 52. Myriad Genetics Recent Development Table 53. Invitae Company Information Table 54. Invitae Business Overview Table 55. Invitae Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Invitae Hereditary Disease Testing Product Portfolio Table 57. Invitae Recent Development Table 58. Illumina Company Information Table 59. Illumina Business Overview Table 60. Illumina Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Illumina Hereditary Disease Testing Product Portfolio Table 62. Illumina Recent Development Table 63. Natera Company Information Table 64. Natera Business Overview Table 65. Natera Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Natera Hereditary Disease Testing Product Portfolio Table 67. Natera Recent Development Table 68. Laboratory Corporation of America Holdings Company Information Table 69. Laboratory Corporation of America Holdings Business Overview Table 70. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Laboratory Corporation of America Holdings Hereditary Disease Testing Product Portfolio Table 72. Laboratory Corporation of America Holdings Recent Development Table 73. F. Hoffmann-La Roche Company Information Table 74. F. Hoffmann-La Roche Business Overview Table 75. F. Hoffmann-La Roche Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. F. Hoffmann-La Roche Hereditary Disease Testing Product Portfolio Table 77. F. Hoffmann-La Roche Recent Development Table 78. Quest Diagnostics Company Information Table 79. Quest Diagnostics Business Overview Table 80. Quest Diagnostics Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Quest Diagnostics Hereditary Disease Testing Product Portfolio Table 82. Quest Diagnostics Recent Development Table 83. CooperSurgical Company Information Table 84. CooperSurgical Business Overview Table 85. CooperSurgical Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. CooperSurgical Hereditary Disease Testing Product Portfolio Table 87. CooperSurgical Recent Development Table 88. Agilent Technologies Company Information Table 89. Agilent Technologies Business Overview Table 90. Agilent Technologies Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Agilent Technologies Hereditary Disease Testing Product Portfolio Table 92. Agilent Technologies Recent Development Table 93. Thermo Fisher Scientific Company Information Table 94. Thermo Fisher Scientific Business Overview Table 95. Thermo Fisher Scientific Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Thermo Fisher Scientific Hereditary Disease Testing Product Portfolio Table 97. Thermo Fisher Scientific Recent Development Table 98. Twist Bioscience Company Information Table 99. Twist Bioscience Business Overview Table 100. Twist Bioscience Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Twist Bioscience Hereditary Disease Testing Product Portfolio Table 102. Twist Bioscience Recent Development Table 103. Sophia Genetics Company Information Table 104. Sophia Genetics Business Overview Table 105. Sophia Genetics Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sophia Genetics Hereditary Disease Testing Product Portfolio Table 107. Sophia Genetics Recent Development Table 108. Fulgent Genetic Company Information Table 109. Fulgent Genetic Business Overview Table 110. Fulgent Genetic Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Fulgent Genetic Hereditary Disease Testing Product Portfolio Table 112. Fulgent Genetic Recent Development Table 113. Medgenome Company Information Table 114. Medgenome Business Overview Table 115. Medgenome Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Medgenome Hereditary Disease Testing Product Portfolio Table 117. Medgenome Recent Development Table 118. CENTOGENE Company Information Table 119. CENTOGENE Business Overview Table 120. CENTOGENE Hereditary Disease Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. CENTOGENE Hereditary Disease Testing Product Portfolio Table 122. CENTOGENE Recent Development Table 123. North America Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Hereditary Disease Testing Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Hereditary Disease Testing Market Share by Country (2021-2026) Table 126. North America Hereditary Disease Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Hereditary Disease Testing Market Share Forecast by Country (2027-2032) Table 128. Europe Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Hereditary Disease Testing Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Hereditary Disease Testing Market Share by Country (2021-2026) Table 131. Europe Hereditary Disease Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Hereditary Disease Testing Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Hereditary Disease Testing Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Hereditary Disease Testing Market Share by Country (2021-2026) Table 136. Asia-Pacific Hereditary Disease Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Hereditary Disease Testing Market Share Forecast by Country (2027-2032) Table 138. Latin America Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Hereditary Disease Testing Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Hereditary Disease Testing Market Share by Country (2021-2026) Table 141. Latin America Hereditary Disease Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Hereditary Disease Testing Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Hereditary Disease Testing Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Hereditary Disease Testing Market Share by Country (2021-2026) Table 146. Middle East & Africa Hereditary Disease Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Hereditary Disease Testing Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Hereditary Disease Testing Product Image Figure 3. Global Hereditary Disease Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Hereditary Disease Testing Market Size (2021-2032) & (US$ Million) Figure 5. Global Hereditary Disease Testing Market Share by Region: 2025 VS 2032 Figure 6. Global Hereditary Disease Testing Market Share by Region (2021-2032) Figure 7. North America Hereditary Disease Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Hereditary Disease Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Hereditary Disease Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Hereditary Disease Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Hereditary Disease Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Hereditary Cancer Testing Image Figure 13. Global Hereditary Cancer Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Hereditary Non-cancer Testing Image Figure 15. Global Hereditary Non-cancer Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Hereditary Disease Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Hereditary Disease Testing Market Share by Type 2025 VS 2032 Figure 18. North America Hereditary Disease Testing Market Size Share by Type (2021-2032) Figure 19. Europe Hereditary Disease Testing Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Hereditary Disease Testing Market Size Share by Type (2021-2032) Figure 21. Latin America Hereditary Disease Testing Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Hereditary Disease Testing Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Laboratory Image Figure 28. Global Laboratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Hereditary Disease Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Hereditary Disease Testing Market Share by Application 2025 VS 2032 Figure 33. North America Hereditary Disease Testing Market Size Share by Application (2021-2032) Figure 34. Europe Hereditary Disease Testing Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Hereditary Disease Testing Market Size Share by Application (2021-2032) Figure 36. Latin America Hereditary Disease Testing Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Hereditary Disease Testing Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Hereditary Disease Testing Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Hereditary Disease Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Hereditary Disease Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Hereditary Disease Testing Market Share by Country (2021-2032) Figure 43. Europe Hereditary Disease Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Hereditary Disease Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hereditary Disease Testing Market Share by Country (2021-2032) Figure 46. Asia-Pacific Hereditary Disease Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Hereditary Disease Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Hereditary Disease Testing Market Share by Country (2021-2032) Figure 49. Latin America Hereditary Disease Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Hereditary Disease Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Hereditary Disease Testing Market Share by Country (2021-2032) Figure 52. Middle East & Africa Hereditary Disease Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Hereditary Disease Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Hereditary Disease Testing Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Hereditary Cancer Testing
  • Hereditary Non-cancer Testing
Applications
  • Hospital
  • Clinic
  • Laboratory
  • Others
Companies covered
  • Myriad Genetics
  • Invitae
  • Illumina
  • Natera
  • Laboratory Corporation of America Holdings
  • F. Hoffmann-La Roche
  • Quest Diagnostics
  • CooperSurgical
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Twist Bioscience
  • Sophia Genetics
  • Fulgent Genetic
  • Medgenome
  • CENTOGENE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Hereditary Disease Testing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Hereditary Disease Testing Market Size by Region (2021-2032)
  5. 1.4.1 Global Hereditary Disease Testing Market Size by Region (2021-2026)
  6. 1.4.2 Global Hereditary Disease Testing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Hereditary Disease Testing Market Size (2021-2032)
  8. 1.5.1 North America Hereditary Disease Testing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Hereditary Disease Testing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Hereditary Disease Testing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Hereditary Disease Testing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Hereditary Disease Testing Market Size Growth Rate (2021-2032)
2 Hereditary Disease Testing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Hereditary Cancer Testing
  3. 2.1.2 Hereditary Non-cancer Testing
  4. 2.2 Global Hereditary Disease Testing Market Size by Type
  5. 2.2.1 Global Hereditary Disease Testing Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Hereditary Disease Testing Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Hereditary Disease Testing Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Hereditary Disease Testing Market Size by Regions
  9. 2.3.1 North America Hereditary Disease Testing Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Hereditary Disease Testing Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Hereditary Disease Testing Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Hereditary Disease Testing Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Hereditary Disease Testing Market Size Breakdown by Type (2021-2026)
3 Hereditary Disease Testing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Laboratory
  5. 3.1.4 Others
  6. 3.2 Global Hereditary Disease Testing Market Size by Application
  7. 3.2.1 Global Hereditary Disease Testing Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Hereditary Disease Testing Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Hereditary Disease Testing Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Hereditary Disease Testing Market Size by Regions
  11. 3.3.1 North America Hereditary Disease Testing Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Hereditary Disease Testing Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Hereditary Disease Testing Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Hereditary Disease Testing Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Hereditary Disease Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Hereditary Disease Testing Industry Trends
  2. 4.2 Hereditary Disease Testing Industry Drivers
  3. 4.3 Hereditary Disease Testing Industry Opportunities and Challenges
  4. 4.4 Hereditary Disease Testing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Hereditary Disease Testing Revenue (2021-2026)
  2. 5.2 Global Hereditary Disease Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Hereditary Disease Testing Key Company Headquarters & Area Served
  4. 5.4 Global Hereditary Disease Testing Company, Product Type & Application
  5. 5.5 Global Hereditary Disease Testing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Hereditary Disease Testing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Hereditary Disease Testing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Hereditary Disease Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Myriad Genetics
  2. 6.1.1 Myriad Genetics Company Information
  3. 6.1.2 Myriad Genetics Business Overview
  4. 6.1.3 Myriad Genetics Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Myriad Genetics Hereditary Disease Testing Product Portfolio
  6. 6.1.5 Myriad Genetics Recent Developments
  7. 6.2 Invitae
  8. 6.2.1 Invitae Company Information
  9. 6.2.2 Invitae Business Overview
  10. 6.2.3 Invitae Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Invitae Hereditary Disease Testing Product Portfolio
  12. 6.2.5 Invitae Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Illumina Hereditary Disease Testing Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Natera
  20. 6.4.1 Natera Company Information
  21. 6.4.2 Natera Business Overview
  22. 6.4.3 Natera Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Natera Hereditary Disease Testing Product Portfolio
  24. 6.4.5 Natera Recent Developments
  25. 6.5 Laboratory Corporation of America Holdings
  26. 6.5.1 Laboratory Corporation of America Holdings Company Information
  27. 6.5.2 Laboratory Corporation of America Holdings Business Overview
  28. 6.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Product Portfolio
  30. 6.5.5 Laboratory Corporation of America Holdings Recent Developments
  31. 6.6 F. Hoffmann-La Roche
  32. 6.6.1 F. Hoffmann-La Roche Company Information
  33. 6.6.2 F. Hoffmann-La Roche Business Overview
  34. 6.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Product Portfolio
  36. 6.6.5 F. Hoffmann-La Roche Recent Developments
  37. 6.7 Quest Diagnostics
  38. 6.7.1 Quest Diagnostics Company Information
  39. 6.7.2 Quest Diagnostics Business Overview
  40. 6.7.3 Quest Diagnostics Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Quest Diagnostics Hereditary Disease Testing Product Portfolio
  42. 6.7.5 Quest Diagnostics Recent Developments
  43. 6.8 CooperSurgical
  44. 6.8.1 CooperSurgical Company Information
  45. 6.8.2 CooperSurgical Business Overview
  46. 6.8.3 CooperSurgical Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 CooperSurgical Hereditary Disease Testing Product Portfolio
  48. 6.8.5 CooperSurgical Recent Developments
  49. 6.9 Agilent Technologies
  50. 6.9.1 Agilent Technologies Company Information
  51. 6.9.2 Agilent Technologies Business Overview
  52. 6.9.3 Agilent Technologies Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Agilent Technologies Hereditary Disease Testing Product Portfolio
  54. 6.9.5 Agilent Technologies Recent Developments
  55. 6.10 Thermo Fisher Scientific
  56. 6.10.1 Thermo Fisher Scientific Company Information
  57. 6.10.2 Thermo Fisher Scientific Business Overview
  58. 6.10.3 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Thermo Fisher Scientific Hereditary Disease Testing Product Portfolio
  60. 6.10.5 Thermo Fisher Scientific Recent Developments
  61. 6.11 Twist Bioscience
  62. 6.11.1 Twist Bioscience Company Information
  63. 6.11.2 Twist Bioscience Business Overview
  64. 6.11.3 Twist Bioscience Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Twist Bioscience Hereditary Disease Testing Product Portfolio
  66. 6.11.5 Twist Bioscience Recent Developments
  67. 6.12 Sophia Genetics
  68. 6.12.1 Sophia Genetics Company Information
  69. 6.12.2 Sophia Genetics Business Overview
  70. 6.12.3 Sophia Genetics Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sophia Genetics Hereditary Disease Testing Product Portfolio
  72. 6.12.5 Sophia Genetics Recent Developments
  73. 6.13 Fulgent Genetic
  74. 6.13.1 Fulgent Genetic Company Information
  75. 6.13.2 Fulgent Genetic Business Overview
  76. 6.13.3 Fulgent Genetic Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Fulgent Genetic Hereditary Disease Testing Product Portfolio
  78. 6.13.5 Fulgent Genetic Recent Developments
  79. 6.14 Medgenome
  80. 6.14.1 Medgenome Company Information
  81. 6.14.2 Medgenome Business Overview
  82. 6.14.3 Medgenome Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Medgenome Hereditary Disease Testing Product Portfolio
  84. 6.14.5 Medgenome Recent Developments
  85. 6.15 CENTOGENE
  86. 6.15.1 CENTOGENE Company Information
  87. 6.15.2 CENTOGENE Business Overview
  88. 6.15.3 CENTOGENE Hereditary Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 CENTOGENE Hereditary Disease Testing Product Portfolio
  90. 6.15.5 CENTOGENE Recent Developments
7 North America
  1. 7.1 North America Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Hereditary Disease Testing Market Size by Country (2021-2026)
  3. 7.3 North America Hereditary Disease Testing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Hereditary Disease Testing Market Size by Country (2021-2026)
  3. 8.3 Europe Hereditary Disease Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Hereditary Disease Testing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Hereditary Disease Testing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Hereditary Disease Testing Market Size by Country (2021-2026)
  3. 10.3 South America Hereditary Disease Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Hereditary Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Hereditary Disease Testing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Hereditary Disease Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst